Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer

Clinical trial NCT00126503 · COMPLETED

Trial details

NCT number: NCT00126503
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chromophobe Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma Papillary Renal Cell Carcinoma Recurrent Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma Stage IV Renal Cell Cancer

Start date: 2005-05-01
Primary completion: 2011-10-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.